Postdoc, PhD, MD
Research area
Clinical research:
-
Metabolic phenotyping
-
Insulin resistance
-
NAD metabolism
-
Precision medicine
-
Artificial intelligence
Research description
Background in translational clinical studies of human metabolism using insulin clamp technique, indirect calorimetry, and tissue biopsies.
Currently an investigator in the multi-center DIASPAX trial—a randomized open-label study comparing empagliflozin, pioglitazone, and semaglutide in patients with type 2 diabetes—aimed at elucidating drug-specific effects on adipose tissue function, cellular composition, and systemic metabolism through deep metabolic phenotyping, including fat biopsies, omics profiling, and insulin clamp studies.